Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Diabetic-foot osteomyelitis

Musculoskeletal medicine and orthopaedics · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Sepsis, spreading deep infection and ischaemia threaten life and limb

Diabetic-foot osteomyelitis may coexist with abscess, necrotising infection, gangrene, critical ischaemia and severe metabolic disturbance while neuropathy masks pain and inflammatory markers remain modest.

Action: Assess ABCDE, glucose and ketones, perfusion and infection severity; obtain cultures without delaying treatment, start urgent intravenous therapy for severe infection, arrange immediate surgical drainage or debridement for deep sepsis, and involve vascular services urgently when ischaemia or gangrene compromises source control and healing.

Synopsis

Detect bone infection beneath a neuropathic ulcer without relying on one negative test, grade systemic and limb threat, obtain useful tissue, restore perfusion and pressure control, and choose medical or surgical treatment coherently.

  • Think osteomyelitis when diabetes accompanies local infection, a deep wound or a chronic ulcer; absence of pain is expected in neuropathy and never reassures.
  • Normal CRP, plain radiographs or probe-to-bone testing do not individually exclude diabetic-foot osteomyelitis under NICE NG19.
  • Grade the whole threat: systemic severity, depth and extent, abscess or necrosis, perfusion, neuropathy, glucose and ketones, renal function and ability to offload.
  • Initial imaging is plain radiography. If osteomyelitis remains suspected but unconfirmed, NICE advises considering MRI to confirm and map disease.
  • Obtain a deep tissue specimen after cleansing and debridement; bone culture and histology are most specific when the diagnosis or pathogen remains uncertain. Avoid treating a surface swab as bone microbiology.
  • Drain abscess and excise non-viable tissue promptly. Coordinate revascularisation and debridement when ischaemia threatens healing rather than assuming either can safely wait in every case.
  • For moderate or severe infection, NICE lists oral treatment first-line when feasible, intravenous treatment for severe illness for at least 48 hours until stabilised, and intravenous review at 48 hours.
  • Course length is based on response and source control: NICE allows a minimum of 7 days and up to 6 weeks for osteomyelitis, using oral therapy for prolonged treatment when possible.

Key red flags

Systemic inflammatory response, confusion, hypotension, tachypnoea, lactate elevation or metabolic decompensation defines severe infection and requires hospital sepsis care rather than ambulatory wound treatment.

Crepitus, bullae, skin anaesthesia, rapidly spreading discoloration or pain beyond visible change raises concern for necrotising infection and demands immediate surgical exploration.

Coldness, rest pain, absent Doppler signals, gangrene or a non-healing wound with poor perfusion requires urgent vascular assessment; neuropathy can make limb-threatening ischaemia painless.

Deep fluctuance, purulent tracking, exposed bone, new deformity or an unstable hot swollen foot suggests abscess, osteomyelitis, septic joint or acute Charcot change and needs multidisciplinary imaging and offloading.

Investigation priorities

01
Initial plain radiographsFirst step

Assess bone destruction, gas, foreign body and deformity.

Management branches

SevereResuscitate and control deep sepsis

Systemic inflammatory response, metabolic decompensation, necrosis or rapidly advancing deep infection is present.

  1. Admit, apply sepsis care, obtain blood cultures and begin severity-appropriate intravenous antibiotics immediately.
  2. Call foot, orthopaedic or vascular surgery urgently and drain abscess or remove necrotic tissue without waiting for perfect imaging.
  3. Assess arterial supply and coordinate revascularisation around immediate source-control needs.
  4. Control glucose and ketones, protect renal function and completely offload the affected foot.
StableConfirm bone involvement and obtain tissue

A deep ulcer suggests osteomyelitis without systemic instability or immediate necrosis.

  1. Clean and debride the wound, document probe-to-bone, perfusion, neuropathy and mechanical loading.
  2. Obtain blood tests and initial radiographs, then use MRI when suspicion remains but radiography is non-confirmatory.
  3. Secure deep tissue or planned bone culture and histology when the result will change prolonged therapy or surgery.
  4. Choose oral treatment first-line when severity and absorption permit, linked to offloading, wound and vascular plans.

Key medicines

Flucloxacillin for selected moderate or severe diabetic-foot infectionNICE first-choice dosing is 1 g orally four times daily or 1–2 g intravenously four times daily; combine with or without gentamicin and/or metronidazole according to severity and microbiological advice, using intravenous treatment for severe infection for at least 48 hours until stabilised.The 1 g oral four-times-daily dose was off label in the cited NICE table; check immediate penicillin allergy, liver function, renal status and sodium load, and never use this fixed choice when resistant organisms, necrotising infection or prior cultures demand another regimen.
Co-amoxiclav as a selected first-choice alternativeNICE lists 500/125 mg orally three times daily or 1.2 g intravenously three times daily, with or without gentamicin; review any intravenous therapy by 48 hours and move to an active oral regimen when clinically possible.Avoid in immediate penicillin hypersensitivity, adjust to renal function and monitor hepatic toxicity; add-on gentamicin requires level and renal monitoring, and no antibiotic replaces drainage, revascularisation or offloading.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG19 Diabetic foot problems: prevention and management
  • BOASt - Fracture Related Infections
  • NICE NG253 - Managing suspected sepsis
  • NICE NG15 Antimicrobial stewardship

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom